Global immunization strategic framework; 2006-2010
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Global immunization strategic framework; 2006-2010
  • Published Date:


Filetype[PDF-457.71 KB]

  • Description:
    "Since 1991, CDC has provided substantial financial and technical support for polio eradication and measles elimination. CDC's yearly investment in global immunization has grown from $3.1 million to $140 million in 2006. In addition, CDC currently has more than 30 staff seconded to international health organizations, such as WHO, UNICEF, Pan American Health Organization, World Bank, and the American Red Cross, providing full-time technical and operational support to priority countries and regions. In keeping with this growth, CDC has a much broader role and greater influence in the field of global immunization than it did even five years ago. In addition to being a key partner in both the global polio eradication initiative and the Measles Initiative, CDC has played a critical role in developing the Global Immunization Vision and Strategy for 2006-2015 (GIVS); has a representative on the Global Alliance for Vaccines and Immunization (GAVI) working group; is an implementing partner in the Hib Initiative, charged by the GAVI Alliance to assist countries to make evidence-based decisions regarding the introduction of Hib vaccine into national programs; and is supporting pilot projects in three countries to strengthen the delivery of routine immunization. In addition, since CDC's last five-year strategic plan for global immunization, much has changed. There has been a renewed commitment from global partners for preventing VPDs among the world's children. This includes $4 billion from the International Finance Facility for Immunization (IFFIm) over the next 10 years and a $750 million investment from the Bill and Melinda Gates Foundation for 2006-2015. Both of these investments will support the GAVI Fund for several initiatives including supporting measles SIAs, strengthening immunization and health systems, eliminating maternal and neonatal tetanus, establishing the polio vaccine stockpile, improving access to underused vaccines, and speeding the development and introduction of new vaccines in GAVI-eligible countries. Investment cases for introduction of rotavirus vaccine and pneumococcal conjugate vaccine are under development." - p. 8
  • Content Notes:
    Includes bibliographical references.
  • Document Type:
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like: